Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lara Šošić, Marta Paolucci, Stephan Flory, Fadi Jebbawi, Thomas M. Kündig & Pål Johansen. (2023) Allergen immunotherapy: progress and future outlook. Expert Review of Clinical Immunology 19:7, pages 745-769.
Read now
Read now
Yan Su, Eliezer Romeu-Bonilla & Teri Heiland. (2017) Next generation immunotherapy for tree pollen allergies. Human Vaccines & Immunotherapeutics 13:10, pages 2402-2415.
Read now
Read now
Peter A. Ricketti, Sultan Alandijani, Chen Hsing Lin & Thomas B. Casale. (2017) Investigational new drugs for allergic rhinitis. Expert Opinion on Investigational Drugs 26:3, pages 279-292.
Read now
Read now
Wendy Ramírez, Virgilio Bourg, Damaris Torralba, Elisa Facenda, Beatriz Tamargo, Bárbara O. González, Gustavo Sierra, Oliver Pérez, Yordanis Perez-Llano & Alexis Labrada. (2017) Safety of a proteoliposome from Neisseria meningitides as adjuvant for a house dust mite allergy vaccine. Journal of Immunotoxicology 14:1, pages 152-159.
Read now
Read now
Marco Caminati, Anna Rita Dama, Ivana Djuric, Marcello Montagni, Michele Schiappoli, Erminia Ridolo, Gianenrico Senna & Giorgio Walter Canonica. (2015) Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Review of Clinical Immunology 11:2, pages 233-245.
Read now
Read now
Giovanni B Pajno, Kari C Nadeau, Giovanni Passalacqua, Lucia Caminiti, Ben Hobson, David C Jay, Stefania Arasi, Fernanda Chiera & Giuseppina Salzano. (2015) The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook. Expert Review of Clinical Immunology 11:1, pages 141-154.
Read now
Read now
Articles from other publishers (65)
Mistrello Gianni. (2023) Evolution of Immunotherapy Against Pollen Allergy. Current Protein & Peptide Science 24:6, pages 488-502.
Crossref
Crossref
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, Charles Ebert, Joshua M. Levy, Sandra Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina Toskala, Jennifer Villwock, Baharudin Abdullah, Cezmi Akdis, Jeremiah A. Alt, Ignacio J. Ansotegui, Antoine Azar, Fuad Baroody, Michael S. Benninger, Jonathan Bernstein, Christopher Brook, Raewyn Campbell, Thomas Casale, Mohamad R. Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Custovic, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie Flanagan, Wytske J. Fokkens, Christine Franzese, Matthew Greenhawt, Amarbir Gill, Ashleigh Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Lang, Desiree Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Loftus, Sonya Marcus, Haidy Marzouk, Jose Mattos, Edward McCoul, Erik Melen, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie Phillips, Michael Platt, Murugappan RamanathanJrJr, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S. Shaker, Aziz Sheikh, Kristine A. Smith, Michael B. Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew White & Luo Zhang. (2023) International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology 13:4, pages 293-859.
Crossref
Crossref
Wendy Ramírez, Damarys Torralba, Virgilio Bourg, Miriam Lastre, Oliver Perez, Alain Jacquet & Alexis Labrada. (2022) Immunogenicity of a novel anti-allergic vaccine based on house dust mite purified allergens and a combination adjuvant in a murine prophylactic model. Frontiers in Allergy 3.
Crossref
Crossref
Mozhdeh Radpour, Samira Choopani, Hamid Gholami Pourbadie & Mohammad Sayyah. (2022) Activating toll-like receptor 4 after traumatic brain injury inhibits neuroinflammation and the accelerated development of seizures in rats. Experimental Neurology 357, pages 114202.
Crossref
Crossref
Kairat Tabynov, Meruert Babayeva, Tair Nurpeisov, Gleb Fomin, Temirzhan Nurpeisov, Ulbossyn Saltabayeva, Sankar Renu, Gourapura J. Renukaradhya, Nikolai Petrovsky & Kaissar Tabynov. (2022) Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model. Frontiers in Immunology 13.
Crossref
Crossref
Anja Ziegler, Judith Olzhausen, Eman Hamza, Ana Stojiljkovic, Michael H. Stoffel, Mattia Garbani, Claudio Rhyner & Eliane Marti. (2022) An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production. Veterinary Immunology and Immunopathology 243, pages 110351.
Crossref
Crossref
Nicki Y.H. Leung, Christine Y.Y. Wai, Tihong Shao, Ka Hou Chu & Patrick S.C. Leung. 2022. Allergic and Immunologic Diseases. Allergic and Immunologic Diseases
187
219
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Maria L. Dias, Karen M. O’Connor, Eugene M. Dempsey, Ken D. O’Halloran & Fiona B. McDonald. (2021) Targeting the Toll-like receptor pathway as a therapeutic strategy for neonatal infection. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 321:6, pages R879-R902.
Crossref
Crossref
Noriaki Aoi, Takafumi Fuchiwaki, Ichiro Morikura, Hideyuki Kawauchi & Tatsunori Sakamoto. (2021) Nasal Administration of Lipopolysaccharide Exacerbates Allergic Rhinitis through Th2 Cytokine Production from Mast Cells. Allergies 1:4, pages 216-224.
Crossref
Crossref
Lin Yang & Rongfei Zhu. (2021) Allergen Preparation in AIT, Now and in the Future. Current Treatment Options in Allergy 8:2, pages 120-132.
Crossref
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Crossref
Thomas Proctor, Elodie Morrough, Otto Fenske, Sarah Allatt, Stephen M. Hughes, Vibha Sharma & Peter D. Arkwright. (2020) Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis. Clinical and Translational Allergy 10:1.
Crossref
Crossref
José Fernando Florido-López, Carmen Andreu-Balaguer, Carmelo Escudero, Marta Seoane-Rodríguez, Mercedes Hernández, Luis Ángel Navarro-Seisdedos, Miguel Torrecillas-Toro, Mónica Anton-Girones, Leticia Herrero-Lifona, Dorimar Brugaletta, Jesús Macías, Rafael Pineda, Maria Ángeles Lara, Julián López-Caballero & Maria José Rojas. (2020) Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study. World Allergy Organization Journal 13:12, pages 100487.
Crossref
Crossref
Matthew D. Heath, Mona O. Mohsen, Pieter-Jan de Kam, Thalia L. Carreno Velazquez, Simon J. Hewings, Matthias F. Kramer, Thomas M. Kündig, Martin F. Bachmann & Murray A. Skinner. (2020) Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in Immunology 11.
Crossref
Crossref
Max E. Kirtland, Daphne C. Tsitoura, Stephen R. Durham & Mohamed H. Shamji. (2020) Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref
Dheeraj Soni, Simon D. Van Haren, Olubukola T. Idoko, Jay T. Evans, Joann Diray-Arce, David J. Dowling & Ofer Levy. (2020) Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference. Frontiers in Immunology 11.
Crossref
Crossref
Montserrat Alvaro‐Lozano, Cezmi A. Akdis, Mubeccel Akdis, Cherry Alviani, Elisabeth Angier, Stefania Arasi, Lisa Arzt‐Gradwohl, Domingo Barber, Raphaëlle Bazire, Ozlem Cavkaytar, Pasquale Comberiati, Stephanie Dramburg, Stephen R. Durham, Aarif O. Eifan, Leandra Forchert, Susanne Halken, Max Kirtland, Umut C. Kucuksezer, Janice A. Layhadi, Paolo Maria Matricardi, Antonella Muraro, Cevdet Ozdemir, Giovanni Battista Pajno, Oliver Pfaar, Ekaterina Potapova, Carmen Riggioni, Graham Roberts, Pablo Rodríguez del Río, Mohamed H. Shamji, Gunter J. Sturm & Marta Vazquez‐Ortiz. (2020) Allergen Immunotherapy in Children User’s Guide. Pediatric Allergy and Immunology 31:S25, pages 1-101.
Crossref
Crossref
Phornsiri Pechsrichuang & Alain Jacquet. (2020) Molecular approaches to allergen‐specific immunotherapy: Are we so far from clinical implementation?. Clinical & Experimental Allergy 50:5, pages 543-557.
Crossref
Crossref
Lizdany Flórez-Álvarez, Lanie Ruiz-Perez, Natalia Taborda & Juan C Hernandez. (2020) Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases. Immunotherapy 12:5, pages 311-322.
Crossref
Crossref
Erika Jensen‐Jarolim, Martin F. Bachmann, Sergio Bonini, Lars Jacobsen, Marek Jutel, Ludger Klimek, Vera Mahler, Ralph Mösges, Philippe Moingeon, Robyn E. O´Hehir, Oscar Palomares, Oliver Pfaar, Harald Renz, Claudio Rhyner, Franziska Roth‐Walter, Michael Rudenko, Johannes Savolainen, Carsten B. Schmidt‐Weber, Claudia Traidl‐Hoffmann & Thomas Kündig. (2020) State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 75:4, pages 746-760.
Crossref
Crossref
Alain Jacquet. (2020) Perspectives in Allergen-Specific Immunotherapy: Molecular Evolution of Peptide- and Protein-Based Strategies. Current Protein & Peptide Science 21:2, pages 203-223.
Crossref
Crossref
A.L. Voskamp, T. Groot Kormelink, R. Gerth van Wijk, P.S. Hiemstra, C. Taube, E.C. de Jong & Hermelijn H. Smits. (2020) Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies. Seminars in Immunopathology 42:1, pages 95-110.
Crossref
Crossref
Andrea M. Kemter & Cathryn R. Nagler. 2020. Mucosal Vaccines. Mucosal Vaccines
855
868
.
Laura Wagenaar, Manon van Roest, Laura J. W. Kruijssen, Peter J. Simons, Louis Boon, Marlotte M. Vonk, Betty C. A. M. van Esch, Leon M. J. Knippels, Johan Garssen, Raymond H. H. Pieters & Joost J. Smit. (2019) Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy. Clinical and Molecular Allergy 17:1.
Crossref
Crossref
Kristopher K. Short, Shannon M. Miller, Lois Walsh, Van Cybulski, Hélène Bazin, Jay T. Evans & David Burkhart. (2019) Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity. Journal of Controlled Release 315, pages 186-196.
Crossref
Crossref
Sviatlana Starchenka, Matthew D. Heath, Alyson Lineberry, Tim Higenbottam & Murray A. Skinner. (2019) Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy. World Allergy Organization Journal 12:11, pages 100087.
Crossref
Crossref
S. Zielen, P. Kuna, W. Aberer, S. Lassmann, O. Pfaar, L. Klimek, A. Wade, K. Kluehr, J. Raab, D. Wessiepe, D. Lee, M.F. Kramer, K. Gunawardena, T. Higenbottam, M.D. Heath, M.A. Skinner & P.J. de Kam. (2019) Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing. World Allergy Organization Journal 12:11, pages 100075.
Crossref
Crossref
Jay T. Evans, Laura S. Bess, Sandra C. Mwakwari, Mark T. Livesay, Yufeng Li, Van Cybulski, David A. Johnson & Hélène G. Bazin. (2019) Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series. ACS Omega 4:13, pages 15665-15677.
Crossref
Crossref
Emma Shardlow & Christopher Exley. (2019)
The size of micro-crystalline tyrosine (MCT®) influences its recognition and uptake by THP-1 macrophages
in vitro
. RSC Advances 9:42, pages 24505-24518.
Crossref
Crossref
Marco Caminati, Alessandra Arcolaci, Massimo Guerriero, Giuseppina Manzotti, Mariangiola Crivellaro, Giovanni Rolla, Filippo Fassio & Gianenrico Senna. (2019) Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. Immunotherapy 11:9, pages 783-794.
Crossref
Crossref
Soghra Hesam, Baharak Khoshkholgh-Sima, Hamid Gholami Pourbadie, Vahab Babapour, Morteza Zendedel & Mohammad Sayyah. (2018) Monophosphoryl Lipid A and Pam3Cys Prevent the Increase in Seizure Susceptibility and Epileptogenesis in Rats Undergoing Traumatic Brain Injury. Neurochemical Research 43:10, pages 1978-1985.
Crossref
Crossref
M. Worm, T. Higenbottam, O. Pfaar, R. Mösges, W. Aberer, K. Gunawardena, D. Wessiepe, D. Lee, M. F. Kramer, M. Skinner, B. Lees & S. Zielen. (2018) Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy. Allergy 73:9, pages 1812-1822.
Crossref
Crossref
Stefan Zielen, Jennis Gabrielpillai, Eva Herrmann, Johannes Schulze, Ralf Schubert & Martin Rosewich. (2018) Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy. Immunotherapy 10:7, pages 529-536.
Crossref
Crossref
Deborah S. Leuthard, Agathe Duda, Sandra N. Freiberger, Sina Weiss, Isabella Dommann, Gabriele Fenini, Emmanuel Contassot, Matthias F. Kramer, Murray A. Skinner, Thomas M. Kündig, Matthew D. Heath & Pål Johansen. (2018) Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling. The Journal of Immunology 200:9, pages 3151-3159.
Crossref
Crossref
Zhenghui Xu & Peter Michael Moyle. (2017) Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands. Bioconjugate Chemistry 29:3, pages 572-586.
Crossref
Crossref
O. A. Svitich, V. F. Lavrov, P. I. Kukina, A. A. Iskandaryan, L. V. Gankovskaya & V. V. Zverev. (2018) Agonists of Receptors of the Innate Immunity and Defective Viral Particles as New Generation of Adjuvants. Epidemiology and Vaccine Prevention 17:1, pages 76-86.
Crossref
Crossref
Pattraporn Satitsuksanoa, Anna Głobińska, Kirstin Jansen, Willem van de Veen & Mübeccel Akdis. (2018) Modified Allergens for Immunotherapy. Current Allergy and Asthma Reports 18:2.
Crossref
Crossref
Mohana Rajakulendran, Elizabeth Huiwen ThamJian Yi SohHP Van Bever. (2018) Novel strategies in immunotherapy for allergic diseases. Asia Pacific Allergy 8:2.
Crossref
Crossref
O. Pfaar, S. Lang, U. Pieper‐Fürst, A. Astvatsatourov, F. Gerich, L. Klimek, M. F. Kramer, Y. Reydelet, K. Shah‐Hosseini & R. Mösges. (2017) Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis. Allergy 73:1, pages 187-195.
Crossref
Crossref
Darrick Carter, Malcolm S. Duthie & Steven G. Reed. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens
103
127
.
M. D Heath, N. J. Swan, A. C. Marriott, N. J. Silman, B. Hallis, C. Prevosto, K. E. Gooch & M. A. Skinner. (2017) Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza. BMC Infectious Diseases 17:1.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2017) Therapeutic intranasal instillation of allergen-loaded microbubbles suppresses experimental allergic asthma in mice. Biomaterials 142, pages 41-51.
Crossref
Crossref
A. K. Ellis, D. C. Tsitoura, D. Quint, W. Powley & L. A. Lee. (2017) Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial. Clinical & Experimental Allergy 47:9, pages 1193-1203.
Crossref
Crossref
Andri Vasou, Nazife Sultanoglu, Stephen Goodbourn, Richard E. Randall & Leondios G. Kostrikis. (2017) Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses. Viruses 9:7, pages 186.
Crossref
Crossref
R. Brehler. (2017) AdjuvanzienAdjuvants. Der Hautarzt 68:4, pages 292-296.
Crossref
Crossref
S. Starchenka, A.J. Bell, J. Mwange, M.A. Skinner & M.D. Heath. (2017) Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities. World Allergy Organization Journal 10, pages 17.
Crossref
Crossref
Maurizio Marogna, Alessandro Massolo & Giovanni Passalacqua. (2017) Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period. World Allergy Organization Journal 10, pages 7.
Crossref
Crossref
M. F. Bachmann & T. M. K?ndig. (2017) Allergen-specific immunotherapy: is it vaccination against toxins after all?. Allergy 72:1, pages 13-23.
Crossref
Crossref
A. Ziegler, V. Gerber & E. Marti. (2017) In vitro effects of the toll-like receptor agonists monophosphoryl lipid A and CpG-rich oligonucleotides on cytokine production by equine cells. The Veterinary Journal 219, pages 6-11.
Crossref
Crossref
C.B. Fox, D. Carter, R.M. Kramer, A.M. Beckmann & S.G. Reed. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
105
127
.
S Hasan Arshad. (2016) An update on allergen immunotherapy. Clinical Medicine 16:6, pages 584-587.
Crossref
Crossref
Pavol Surda & Wytske J. Fokkens. (2016) Novel, Alternative, and Controversial Therapies of Rhinitis. Immunology and Allergy Clinics of North America 36:2, pages 401-423.
Crossref
Crossref
Jani Rahkila, Rajib Panchadhayee, Ana Ardá, Jesús Jiménez-Barbero, Johannes Savolainen & Reko Leino. (2016) Acetylated Trivalent Mannobioses: Chemical Modification, Structural Elucidation, and Biological Evaluation. ChemMedChem 11:6, pages 562-574.
Crossref
Crossref
Keith BiggadikeMahbub AhmedDoug I. BallDiane M. CoeDeidre A. Dalmas Wilk, Chris D. EdwardsBob H. GibbonCharlotte J. HardyStephen A. HermitageJoanne O. HesseyAimee E. Hillegas, Stephen C. HughesLinos LazaridesXiao Q. LewellAmanda LucasDavid N. MallettMark A. PriceFiona M. PriestDiana J. QuintPoonam ShahAnesh SitaramStephen A. SmithRichard StockerNaimisha A. TrivediDaphne C. TsitouraVictoria Weller. (2016)
Discovery of 6-Amino-2-{[(1
S
)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8
H
-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
. Journal of Medicinal Chemistry 59:5, pages 1711-1726.
Crossref
Crossref
Nhung T Nguyen, Esther Raskopf, Kija Shah-Hosseini, Gregor Zadoyan & Ralph Mösges. (2016) A review of allergoid immunotherapy: is cat allergy a suitable target?. Immunotherapy 8:3, pages 331-349.
Crossref
Crossref
Martin Rosewich, Katharina GirodStefan ZielenRalf SchubertJohannes Schulze. (2016) Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies. Allergy, Asthma & Immunology Research 8:3, pages 257.
Crossref
Crossref
A.J. Bell, M.D. Heath, S.J. Hewings & M.A. Skinner. (2015) The adsorption of allergoids and 3-O-desacyl-4′-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy. Journal of Inorganic Biochemistry 152, pages 147-153.
Crossref
Crossref
D Tsitoura, C Ambery, M Price, W Powley, S Garthside, K Biggadike & D Quint. (2015) Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement. Clinical Pharmacology & Therapeutics 98:4, pages 369-380.
Crossref
Crossref
Ekaterini Tiligada, Masaru Ishii, Carlo Riccardi, Michael Spedding, Hans-Uwe Simon, Mauro Martins Teixeira, Mario Landys Chovel Cuervo, Stephen T Holgate & Francesca Levi-Schaffer. (2015) The expanding role of immunopharmacology: IUPHAR Review 16. British Journal of Pharmacology 172:17, pages 4217-4227.
Crossref
Crossref
Thomas M. Kündig, Ludger Klimek, Philipp Schendzielorz, Wolfgang A. Renner, Gabriela Senti & Martin F. Bachmann. (2014) Is The Allergen Really Needed in Allergy Immunotherapy?. Current Treatment Options in Allergy 2:1, pages 72-82.
Crossref
Crossref
Koa Hosoki, Istvan Boldogh & Sanjiv Sur. (2015) Innate responses to pollen allergens. Current Opinion in Allergy & Clinical Immunology 15:1, pages 79-88.
Crossref
Crossref
Thomas B. Casale & Jeffrey R. Stokes. (2014) Immunotherapy: What lies beyond. Journal of Allergy and Clinical Immunology 133:3, pages 612-619.
Crossref
Crossref
Jeffrey R. Stokes & Thomas B. Casale. (2013) Novel Approaches of Immunotherapy. Current Treatment Options in Allergy 1:1, pages 58-67.
Crossref
Crossref
Wendy Ramirez, Damarys Torralba, Virgilio Bourg, Miriam Lastre, Oliver Perez & Alexis Labrada. (2022) Immunogenicity of a Novel Anti-Allergic Vaccine Based on Purified Allergens from House Dust Mite and a Combination Adjuvant in a Murine Prophylactic Model. SSRN Electronic Journal.
Crossref
Crossref